Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ketorolac tromethamine + levofloxacin by NTC for Bacterial Conjunctivitis: Likelihood of Approval
Ketorolac tromethamine + levofloxacin is under clinical development by NTC and currently in Phase II for Bacterial Conjunctivitis. According to...